Fischer et al identified that miR-17,miR-18a, miR-20a and miR-93 all function as the CBF-AML fusion proteins in negative regulating their target RUNX1 and the RUNX1-miR-221-KIT axis [74]. Here, RUNX1 is linked to acute myeloid leukemia.